Clinical Trials Browser

Phase 2 × Mesothelioma × Ipilimumab × Clear all

NCT04300244 2024-02-29

NIPU

Phase 2 Active not recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma, Neoplasms

NCT05041062 2024-01-03

A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

Phase 2 Completed

2 enrolled 8 charts

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT02716272 2021-02-10

MAPS2

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma